Related Experiment Videos
Hereditary cancers: from discovery to intervention
1Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Journal of the National Cancer Institute. Monographs
|January 1, 1995
Summary
This conference focused on hereditary breast, ovarian, and colon cancers. Discoveries in gene mutations offer insights into cancer predisposition and potential intermediate endpoints for prevention strategies.
Area of Science:
- Oncology
- Genetics
- Cancer Research
Background:
- Hereditary cancers of the breast, ovary, and colon are common, fatal, and highly heritable.
- Significant progress has been made in identifying genes associated with hereditary cancer predisposition.
- Understanding the molecular basis of these cancers is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To review the current understanding of hereditary cancers of the breast, ovary, and colon.
- To discuss the role of gene mutations in cancer predisposition.
- To explore the potential for intermediate endpoints in cancer prevention research.
Main Methods:
- Review of cloned genes and mapped genetic loci associated with hereditary cancers.
- Discussion of molecular details of hereditary colon cancer, including APC gene and DNA mismatch repair genes.
- Exploration of the concept of intermediate endpoints for monitoring preventive measures.
Main Results:
- Four genes predisposing to hereditary breast, ovarian, and colon cancers have been cloned, with another mapped.
- The APC gene in familial polyposis coli leads to polyps with low malignant transformation probability, offering an intermediate endpoint.
- Mutations in DNA mismatch repair genes accelerate polyp-to-cancer transformation in hereditary nonpolyposis colon cancer.
Conclusions:
- The identification of specific genes and molecular pathways provides a foundation for understanding hereditary cancer risk.
- The concept of intermediate endpoints, as exemplified in colon cancer, could be valuable for breast cancer research.
- Further research into prevention and treatment strategies is essential, contingent on the availability of promising measures for individuals at high risk.